✦ LIBER ✦

A Phase I Dose Escalation Study of Stereotactic Body Radiation Therapy (SBRT) for Patients with Hepatic Metastases - Evidence of a Dose-response Relationship

✍ Scribed by W. Rule; T. Boike; L. Cho; R. Abdulrahman; J.H. Heinzerling; A. Perkins; R. Foster; L. Nedzi; R. Timmerman

Book ID: 108148908
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 53 KB
Volume: 75
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2009.07.088

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I dose escalating study of inten

A phase I dose escalating study of intensity modulated radiation therapy (IMRT) for the treatment of glioblastoma multiforme (GBM)

✍ E.G Shaw; V Stieber; S Tatter; T Ellis; W Hinson; W Kearns; J.D Bourland; M Munl 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 28 KB

Phase I dose-escalation study of thoraci

Phase I dose-escalation study of thoracic irradiation with concurrent chemotherapy for patients with limited small cell lung cancer (LSCLC). Radiation therapy oncology group RTOG

✍ R Komaki; S Swann; D Ettinger; B Glisson; A Sandler; B Movsas; R Byhardt 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 19 KB

Phase I/II conformal three-dimensional r

Phase I/II conformal three-dimensional radiation therapy dose escalation study in patients with supratentorial glioblastoma multiforme: Report of the radiation therapy oncology group 98–03 protocol

✍ M. Werner-Wasik; W. Seiferheld; J. Michalski; M. Gilbert; J. Purdy; J. Simpson; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 98 KB

A Phase I–II trial of escalating doses o

A Phase I–II trial of escalating doses of mitoxantrone with fixed doses of cytarabine plus fludarabine as salvage therapy for patients with acute leukemia and the blastic phase of chronic myelogenous leukemia

✍ Charles A. Koller; Hagop M. Kantarjian; Eric J. Feldman; Susan O'Brien; Mary Bet 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

## BACKGROUND. Cytarabine is an essential drug for inducing remission of acute myelogenous leukemia, and it is also one the most effective drugs used as salvage therapy for patients with all types of relapsed acute leukemia. Nevertheless, there is considerable room for improvement in the treatment

Phase I dose escalation study of weekly

Phase I dose escalation study of weekly ixabepilone, an epothilone analog, in patients with advanced solid tumors who have failed standard therapy

✍ Ahmad Awada; Martine J. Piccart; Suzanne F. Jones; Ronald A. Peck; Thierry Gil; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 358 KB

A phase I/II study of sequential, dose-e

A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas

✍ Carsten Bokemeyer; Anke Franzke; Jörg T. Hartmann; Christoph Schöber; Lubomir Ar 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

ide combined with full dose doxorubicin chemotherapy supported with peripheral blood stem cells (PBSC) and granulocyte-colony stimulating factor (G-CSF) in